Telomeric noncoding RNA: Telomeric repeat-containing RNA in telomere biology

Wiley Interdisciplinary Reviews: RNA

Volumn 5, Issue 3, 2014, Pages 407-419

  Cusanelli, Emilio ^a   Chartrand, Pascal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

7 METHYLGUANOSINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; HISTONE METHYLTRANSFERASE; LONG UNTRANSLATED RNA; POLYNUCLEOTIDE ADENYLYLTRANSFERASE; RNA BINDING PROTEIN; RNA POLYMERASE II; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT CONTAINING RNA; UNCLASSIFIED DRUG; HETEROCHROMATIN; UNTRANSLATED RNA;

BIOGENESIS; CARCINOGENESIS; CELL FUNCTION; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; CONSTITUTIVE HETEROCHROMATIN; CPG ISLAND; DNA METHYLATION; DNA REPLICATION; DNA RNA HYBRIDIZATION; FACE MALFORMATION; GENOMIC INSTABILITY; HETEROCHROMATIN; HISTONE METHYLATION; HUMAN; IMMUNE DEFICIENCY; MMUNODEFICIENCY CENTROMERIC REGION INSTABILITY FACIAL ANOMALIES SYNDROME; MOLECULAR BIOLOGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENESCENCE; TELOMERE; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TRANSCRIPTION INITIATION SITE; ANIMAL; CHEMISTRY; FACE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANIMALS; FACE; GENE EXPRESSION REGULATION; HETEROCHROMATIN; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NEOPLASMS; RNA, UNTRANSLATED; TELOMERE;

EID: 84920163445     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1220     Document Type: Review

References (65)

1. O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 2010, 11:171-181.
2. Jain D, Cooper JP. Telomeric strategies: means to an end. Annu Rev Genet 2010, 44:243-269.
3. Deng Y, Chan SS, Chang S. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 2008, 8:450-458.
4. Bernardes de Jesus B, Blasco MA. Telomerase at the intersection of cancer and aging. Trends Genet 2013, 29:513-520.
5. Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet 2008, 42:301-334.
6. Hazelrigg T, Levis R, Rubin GM. Transformation of white locus DNA in Drosophila: dosage compensation, zeste interaction, and position effects. Cell 1984, 36:469-481.
7. Gottschling DE, Aparicio OM, Billington BL, Zakian VA. Position effect at S. cerevisiae telomeres: reversible repression of Pol II transcription. Cell 1990, 63:751-762.
8. Ottaviani A, Gilson E, Magdinier F. Telomeric position effect: from the yeast paradigm to human pathologies? Biochimie 2008, 90:93-107.
9. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007, 318:798-801.
10. Schoeftner S, Blasco MA. Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 2008, 10:228-236.
11. Luke B, Panza A, Redon S, Iglesias N, Li Z, Lingner J. The Rat1p 5' to 3' exonuclease degrades telomeric repeat-containing RNA and promotes telomere elongation in Saccharomyces cerevisiae. Mol Cell 2008, 32:465-477.
12. Vrbsky J, Akimcheva S, Watson JM, Turner TL, Daxinger L, Vyskot B, Aufsatz W, Riha K. siRNA-mediated methylation of Arabidopsis telomeres. PLoS Genet 2010, 6:e1000986.
13. Porro A, Feuerhahn S, Reichenbach P, Lingner J. Molecular dissection of telomeric repeat-containing RNA biogenesis unveils the presence of distinct and multiple regulatory pathways. Mol Cell Biol 2010, 30:4808-4817.
14. Nergadze SG, Farnung BO, Wischnewski H, Khoriauli L, Vitelli V, Chawla R, Giulotto E, Azzalin CM. CpG-island promoters drive transcription of human telomeres. RNA 2009, 15:2186-2194.
15. Deng Z, Wang Z, Stong N, Plasschaert R, Moczan A, Chen H-S, Hu S, Wikramasinghe P, Davuluri RV, Bartolomei MS, et al. A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J 2012, 31:4165-4178.
16. Feuerhahn S, Iglesias N, Panza A, Porro A, Lingner J. TERRA biogenesis, turnover and implications for function. FEBS Lett 2010, 584:3812-3818.
17. Pfeiffer V, Lingner J. TERRA promotes telomere shortening through exonuclease 1-mediated resection of chromosome ends. PLoS Genet 2012, 8:e1002747.
18. Bah A, Wischnewski H, Shchepachev V, Azzalin CM. The telomeric transcriptome of Schizosaccharomyces pombe. Nucleic Acids Res 2012, 40:2995-3005.
19. Greenwood J, Cooper JP. Non-coding telomeric and subtelomeric transcripts are differentially regulated by telomeric and heterochromatin assembly factors in fission yeast. Nucleic Acids Res 2012, 40:2956-2963.
20. Arnoult N, Van Beneden A, Decottignies A. Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1alpha. Nat Struct Mol Biol 2012, 19:948-956.
21. Iglesias N, Redon S, Pfeiffer V, Dees M, Lingner J, Luke B. Subtelomeric repetitive elements determine TERRA regulation by Rap1/Rif and Rap1/Sir complexes in yeast. EMBO Rep 2011, 12:587-593.
22. Wellinger RJ, Zakian VA. Everything you ever wanted to know about Saccharomyces cerevisiae telomeres: beginning to end. Genetics 2012, 191:1073-1105.
23. Ng LJ, Cropley JE, Pickett HA, Reddel RR, Suter CM. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription. Nucleic Acids Res 2009, 37:1152-1159.
24. Farnung BO, Brun CM, Arora R, Lorenzi LE, Azzalin CM. Telomerase efficiently elongates highly transcribing telomeres in human cancer cells. PLoS ONE 2012, 7:e35714.
25. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, Blasco MA. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006, 8:416-424.
26. Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 2011, 6:63-75.
27. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009, 4:141-154.
28. Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL. MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol 2009, 29:4519-4526.
29. Azzalin CM, Lingner J. Telomeres: the silence is broken. Cell Cycle 2008, 7:1161-1165.
30. Deng Z, Wang Z, Xiang C, Molczan A, Baubet V, Conejo-Garcia J, Xu X, Lieberman PM, Dahmane N. Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci 2012, 125:4383-4394.
31. Cusanelli E, Romero CAP, Chartrand P. Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol Cell 2013, 51:780-791.
32. Marcand S, Brevet V, Gilson E. Progressive cis-inhibition of telomerase upon telomere elongation. EMBO J 1999, 18:3509-3519.
33. Kyrion G, Liu K, Liu C, Lustig AJ. RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae. Genes Dev 1993, 7:1146-1159.
34. Benetti R, Garcia-Cao M, Blasco MA. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 2007, 39:243-250.
35. Smirnova A, Gamba R, Khoriauli L, Vitelli V, Nergadze SG, Giulotto E. TERRA expression levels do not correlate with telomere length and radiation sensitivity in human cancer cell lines. Front Oncol 2013:3.
36. Schoeftner S, Blanco R, de Silanes IL, Munoz P, Gomez-Lopez G, Flores JM, Blasco MA. Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations. Proc Natl Acad Sci 2009, 106:19393-19398.
37. Benetti R, Schoeftner S, Munoz P, Blasco MA. Role of TRF2 in the assembly of telomeric chromatin. Cell Cycle 2008, 7:3461-3468.
38. Thijssen PE, Tobi EW, Balog J, Schouten SG, Kremer D, El Bouazzaoui F, Henneman P, Putter H, Eline Slagboom P, Heijmans BT, et al. Chromatin remodeling of human subtelomeres and TERRA promoters upon cellular senescence: commonalities and differences between chromosomes. Epigenetics 2013, 8:512-521.
39. Van Beneden A, Arnoult N, Decottignies A. Telomeric RNA expression: length matters. Front Oncol 2013:3.
40. Blasco MA. The epigenetic regulation of mammalian telomeres. Nat Rev Genet 2007, 8:299-309.
41. Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM. TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 2009, 35:403-413.
42. de Silanes IL, d'Alcontres MS, Blasco MA. TERRA transcripts are bound by a complex array of RNA-binding proteins. Nat Commun 2010, 1:33.
43. Scheibe M, Arnoult N, Kappei D, Buchholz F, Decottignies A, Butter F, Mann M. Quantitative interaction screen of telomeric repeat-containing RNA reveals novel TERRA regulators. Genome Res 2013.
44. Xu Y, Kaminaga K, Komiyama M. G-quadruplex formation by human telomeric repeats-containing RNA in Na+ solution. J Am Chem Soc 2008, 130:11179-11184.
45. Martadinata H, Phan AT. Structure of propeller-type parallel-stranded RNA G-quadruplexes, formed by human telomeric RNA sequences in K+ solution. J Am Chem Soc 2009, 131:2570-2578.
46. Randall A, Griffith JD. Structure of long telomeric RNA transcripts: the G-rich RNA forms a compact repeating structure containing G-quartets. J Biol Chem 2009, 284:13980-13986.
47. Balk B, Maicher A, Dees M, Klermund J, Luke-Glaser S, Bender K, Luke B. Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat Struct Mol Biol 2013, 20:1199-1205.
48. Pfeiffer V, Crittin J, Grolimund L, Lingner J. The THO complex component Thp2 counteracts telomeric R-loops and telomere shortening. EMBO J 2013, 32:2861-2871.
49. Lai L-T, Lee PJ, Zhang L-F. Immunofluorescence protects RNA signals in simultaneous RNA-DNA FISH. Exp Cell Res 2012, 319:46-55.
50. Zhang L-F, Ogawa Y, Ahn JY, Namekawa SH, Silva SS, Lee JT. Telomeric RNAs mark sex chromosomes in stem cells. Genetics 2009, 182:685-698.
51. Sandell LL, Gottschling DE, Zakian VA. Transcription of a yeast telomere alleviates telomere position effect without affecting chromosome stability. Proc Natl Acad Sci 1994, 91:12061-12065.
52. Maicher A, Kastner L, Dees M, Luke B. Deregulated telomere transcription causes replication-dependent telomere shortening and promotes cellular senescence. Nucleic Acids Res 2012, 40:6649-6659.
53. Redon S, Reichenbach P, Lingner J. The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res 2010, 38:5797-5806.
54. Gallardo F, Laterreur N, Cusanelli E, Ouenzar F, Querido E, Wellinger RJ, Chartrand P. Live cell imaging of telomerase RNA dynamics reveals cell cycle-dependent clustering of telomerase at elongating telomeres. Mol Cell 2011, 44:819-827.
55. Postepska-Igielska A, Krunic D, Schmitt N, Greulich-Bode KM, Boukamp P, Grummt I. The chromatin remodelling complex NoRC safeguards genome stability by heterochromatin formation at telomeres and centromeres. EMBO Rep 2013, 14:704-710.
56. Flynn RL, Centore RC, O'Sullivan RJ, Rai R, Tse A, Songyang Z, Chang S, Karlseder J, Zou L. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 2011, 471:532-536.
57. Le PN, Maranon DG, Altina NH, Battaglia CLR, Bailey SM. TERRA, hnRNP A1 and DNA-PKcs interactions at human telomeres. Front Oncol 2013:3.
58. Sampl S, Pramhas S, Stern C, Preusser M, Marosi C, Holzmann K. Expression of telomeres in astrocytoma WHO grade II to IV: TERRA level correaltes with telomere length, telomerase activity and advanced clinical grade. Transl Oncol 2010, 5:56-65.
59. Vitelli V, Falvo P, Khoriauli L, Smirnova A, Gamba R, Santagostino M, Nergadze SG, Giulotto E. More on the lack of correlation between TERRA expression and telomere length. Front Oncol 2013:3.
60. Ogrunc M, d'Adda di Fagagna F. Never-ageing cellular senescence. Eur J Cancer 2011, 47:1616-1622.
61. Yehezkel S, Segev Y, Viegas-Péquignot E, Skorecki K, Selig S. Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet 2008, 17:2776-2789.
62. Xu G-L, Bestor TH, Bourc'his D, Hsieh C-L, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402:187-191.
63. Gisselsson D, Shao C, Tuck-Muller C, Sogorovic S, Pålsson E, Smeets D, Ehrlich M. Interphase chromosomal abnormalities and mitotic missegregation of hypomethylated sequences in ICF syndrome cells. Chromosoma 2005, 114:118-126.
64. Deng Z, Campbell AE, Lieberman PM. TERRA, CpG methylation, and telomere heterochromatin: lessons from ICF syndrome cells. Cell Cycle 2010, 9:69-74.
65. Yehezkel S, Shaked R, Sagie S, Berkovitz R, Shachar-Bener H, Segev Y, Selig S. Characterization and rescue of telomeric abnormalities in ICF syndrome type I fibroblasts. Front Oncol 2013:3.